Mesoblast (MEOBF) Shares Outstanding (Diluted) (2014 - 2026)
Powered by 
Analysis
Mesoblast (MEOBF) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.13 Bn | 9.29 Bn | 112.79 Mn | 30.66 Mn |
| 2 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | 96.51 Mn |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | 450.19 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn | 184.32 Mn |
| 5 | uniQure | 3.08 Bn | 3.08 Bn | 5.49 Mn | 66.24 Mn |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | 104.33 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 413.69 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | 105.43 Mn |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn | 52.31 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | 129.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 129.49 Mn |
| Dec 31, 2025 | 120.78 Mn |
| Jun 30, 2025 | 120.78 Mn |
| Dec 31, 2024 | 98.67 Mn |
| Jun 30, 2024 | 98.67 Mn |
| Dec 31, 2023 | 73.90 Mn |
| Jun 30, 2023 | 73.90 Mn |
| Mar 31, 2023 | 64.89 Mn |
| Dec 31, 2022 | 64.89 Mn |
| Sep 30, 2022 | 64.89 Mn |
| Jun 30, 2022 | 64.89 Mn |
| Mar 31, 2022 | 60.51 Mn |
| Dec 31, 2021 | 60.51 Mn |
| Sep 30, 2021 | 60.51 Mn |
| Jun 30, 2021 | 60.51 Mn |
| Mar 31, 2021 | 52.88 Mn |
| Dec 31, 2020 | 52.88 Mn |
| Sep 30, 2020 | 52.88 Mn |
| Jun 30, 2020 | 52.88 Mn |
| Mar 31, 2020 | 49.44 Mn |